[1]
V. Sammartano, S. Ciofini, B. Esposito Vangone, C. Carrara, M. Bocchia, and A. Gozzetti, “Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma”, Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025051, Jun. 2025.